Evidence map›Paper›PMID 25275297›Full record

ArticleOncotarget2014

Oncogene addiction: resetting the safety switch?

Yulin Li, Peter S Choi, Dean W Felsher

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. E2F6 is essential for cell viability in breast cancer cells during replication stress.Turkish journal of biology = Turk biyoloji dergisi · 2019
    Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Yulin LiDivision of Oncology, Departments of Medicine and Pathology, Stanford University, Stanford, CA.
Peter S ChoiDivision of Oncology, Departments of Medicine and Pathology, Stanford University, Stanford, CA.
Dean W FelsherDivision of Oncology, Departments of Medicine and Pathology, Stanford University, Stanford, CA.

Funding

Modeling and Predicting Therapeutic Resistance of CancerU01CA188383 · NCI · STANFORD UNIVERSITY · PI FELSHER, DEAN W, GAMBHIR, SANJIV S · 2014 to 2018
$3.2M
Mechanisms by which Oncogene Inactivation Elicits Tumor Cell DeathR01CA170378 · NCI · STANFORD UNIVERSITY · PI FELSHER, DEAN W · 2012 to 2015
$2.1M
NCI NIH HHS R01 CA170378NCI NIH HHS U01 CA188383
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cell ProliferationCell SurvivalAnimalsLymphomaMicroRNAsProto-Oncogene Proteins c-mycMicroRNAsProto-Oncogene Proteins c-myc

Identifiers

PMID25275297
PMCPMC4226662

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.